Business Standard
Home / Companies / News / Is Indian pharma vulnerable in US?

Is Indian pharma vulnerable in US?

Image

Joe C Mathew New Delhi
Last Updated : Jan 28 2013 | 8:31 PM IST
  

Also Read

EU, US oppose Novartis' Glivec move

EU, US oppose Novartis' Glivec move

Cipla launches anti-malaria global initiative

Cipla launches anti-malaria global initiative

Drug exports to Africa fall

Drug exports to Africa fall

Waxman, EU Parliamentarians join agitation against Novartis

Waxman, EU Parliamentarians join agitation against Novartis

Overdose?

Overdose?

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 18 2007 | 12:00 AM IST

Explore News

Market LIVEParliament Winter Session 2024 LIVELatest News LIVEMarket TodayStocks To Watch TodayGold-Silver Price TodayIND vs AUS 3rd Test Day 4 LIVESai Life Sciences IPO AllotmentIPO NewsBusiness Standard at 50
HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2024 Business Standard Private Ltd. All rights reserved
LinkedIN Icon